NanoCytomics
Pre-clinicalPowered by a passion to effect dramatic improvements in cancer survival rates, NanoCytomics’ team members are developing novel, highly accurate, low-cost, non-invasive tests for use in primary care physicians’ offices.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $2.5M
About
Powered by a passion to effect dramatic improvements in cancer survival rates, NanoCytomics’ team members are developing novel, highly accurate, low-cost, non-invasive tests for use in primary care physicians’ offices.
DiagnosticsOncology
Funding History
1Total raised:$2.5M
Seed$2.5MJun 15, 2022